Marine Biotech S.L. (Marine Biotech or MBI) has been designed to be the holding company of a solid European integrated fish and seafood group of companies to supply international clients that demand high quality sea products. MBI key competitive factors are: The Team of experts to support the project. Actual Assets include: Fish farm, juvenile […]

• Main Activity: Trading and processing of high value added fish and seafood. • Actual Sales: Euro 20M. Actual EBITDA 1.2M. • Wide range of products: Octopus, cuttlefish, squid, prawn, lobster, cod, sole, hake, monkfish, etc. • THE COMPANY has its own raw material supply channels in place. Actually purchasing from fisheries in the Northern […]

There is a very good opportunity to acquire THE COMPANY as the owners have decided to sell 100% of the shares to a solvent investment group who can bring it a new level and ensure expansion and future growth. THE COMPANY was founded in Spain 20 years ago and has been consistently growing since then. […]

Due to the unique and privileged access to the fish industry in the South of Europe, MBI executives have the capacity to identify great companies to be acquired. This brings the opportunity to create a specialized group of companies with global international access to fish raw material and strong distribution capacity to supply international markets. […]